D27.505.954.248

4 trials

Sponsors

Hospital Perola Byington, Hospital São Rafael/Monte Tabor-BA, Universidade Federal do Ceará, Fundação Pio XII - Hospital de Câncer de Barretos

Conditions

Malignant neoplasm of breastMantle Cell LymphomaMyelodysplastic SyndromesNausea

Phase 3

Study to Evaluate Imetelstat (JNJ- 63935937) in Subjects with International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

RecruitingRBR-9jqhyc

Fundação Pio XII - Hospital de Câncer de BarretosMyelodysplastic Syndromes

Start: 2015-02-01Updated: 2025-10-27

A Study of Bendamustine and Rituximab (BR) Alone Versus in Combination with Acalabrutinib (ACP-196) in Subjects with Previously Untreated Mantle Cell Lymphoma

RecruitingRBR-2xt4yk

Hospital São Rafael/Monte Tabor-BAMantle Cell Lymphoma

Start: 2017-11-01Updated: 2025-10-27

A placebo-controlled study of Ipatasertib in combination with Atezolizumab and Paclitaxel as a treatment for patients with advanced breast cancer

RecruitingRBR-2x8xh8

Hospital Perola ByingtonMalignant neoplasm of breast

Start: 2019-07-17Updated: 2025-10-27

Unknown Phase

Phone calls follow-up in the care of cancer patients under ambulatorial anti-cancer therapy: randomized clinical test

Active, not recruitingRBR-9g7kvc

Universidade Federal do CearáNausea

Start: 2018-02-15Updated: 2025-10-27